DW Insights & Inquiries
Subacute cutaneous lupus erythematosus has been associated with, or induced by, immune checkpoint inhibitors. Clinicians should be familiar with this information as the number of such cases will likely increase.
Consider using the term “reactive granulomatous dermatitis” (RGD) in your dermatologic practice, prompting search for an underlying associated systemic condition following a thorough review of systems.
Dupilumab may cause a variety of erythematous rashes, usually distributed on the face and neck. Dermatologists have to consider several clinical scenarios before embarking on the appropriate treatment for this adverse reaction.
Facial discoid dermatosis is a recently defined recalcitrant disorder that requires differentiation from psoriasis, tinea, and cutaneous lupus. Most cases suggest a relationship to pityriasis rubra pilaris, but this requires further study.
Nail-biting (onychophagia) is a common problem that can range in severity, with potential complications beyond the nails. Treatment, if desired, must be tailored to the patient with nonpharmacologic and pharmacologic approaches.
Surgical site infections appear most commonly on the lower extremities, which may be more common in a wound healing by secondary intention. We must recognize patients at risk and determine the role of antibiotic prophylaxis.
To improve the practice of dermatology, while being stimulating, practical, thought-provoking, and enlightening by offering critical perspectives on current dermatologic literature meant to be used in the clinic today and in the future.
Explore Dermatology World Insights and Inquiries clinical topics by practice focus, condition, and medical journal source.
All content solely developed by the American Academy of Dermatology
The American Academy of Dermatology gratefully acknowledges support from Bristol Myers Squibb.
